BrainCool AB (publ) (STO:BRAIN)

Market Cap	287.08M -30.9%
Revenue (ttm)	44.02M -1.2%
Net Income	-36.81M
EPS	-0.12
Shares Out	394.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,394
Open	0.7420
Previous Close	0.7400
Day's Range	0.7270 - 0.7620
52-Week Range	0.4105 - 1.6800
Beta	1.46
Analysts	Strong Buy
Price Target	0.80 (0.0%)
Earnings Date	Aug 14, 2026

About BrainCool AB

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient’s temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient’s nostrils with a catheter; Cooral system provides medical professionals a way to reduce the ri...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 15
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BRAIN

Financial Performance

In 2025, BrainCool AB's revenue was 44.62 million, an increase of 5.01% compared to the previous year's 42.49 million. Losses were -37.05 million, -16.26% less than in 2024.